Company · CIK 0001517022
Akebia Therapeutics, Inc.
AKBASearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$0.80−$0.01 (−1.71%)
AKBA · Last trade
- Prev close
- $0.81
- Range (29d)
- $0.80 – $0.98
On the record
Recent filings
- 10-QAKBAQuarterly update0001517022-26-000051 · 10.6 MBSEC(opens sec.gov)
- 8-KAKBACurrent report0001517022-26-000050 · 267.7 KBSEC(opens sec.gov)
- 8-KAKBACurrent report0001517022-26-000047 · 228.0 KBSEC(opens sec.gov)
- 8-KAKBACurrent report0001517022-26-000043 · 181.7 KBSEC(opens sec.gov)
- 10-QAKBAQuarterly update0001517022-26-000039 · 9.7 MBSEC(opens sec.gov)
- 8-KAKBACurrent report0001517022-26-000038 · 270.7 KBSEC(opens sec.gov)
- 8-KAKBACurrent report0001517022-26-000024 · 177.7 KBSEC(opens sec.gov)
- 10-KAKBAAnnual report0001517022-26-000020 · 17.3 MBSEC(opens sec.gov)
- 8-KAKBACurrent report0001517022-26-000019 · 304.9 KBSEC(opens sec.gov)
- 8-KAKBACurrent report0001517022-26-000008 · 387.6 KBSEC(opens sec.gov)
Insiders
- ADAMS ADRIANDirector
- Amello JasonSVP, CFO & Treasurer
- Burke Steven KeithSVP, Chief Medical Officer
- Butler John P.Director, CEO and President
- Canute Scott ADirector
- Clayman Michael D.Director
- Cotreau ViolettaSVP, Chief Accounting Officer
- Dahan MichelSVP, Chief Operating Officer
- Dalal AnupamDirector
- Enyedy Mark JDirector
Tickers
Addresses
business
245 FIRST STREET
CAMBRIDGE, MA, 02142
mailing
245 FIRST STREET
CAMBRIDGE, MA, 02142
Same industry